1. Home
  2. KALA vs FCUV Comparison

KALA vs FCUV Comparison

Compare KALA & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • FCUV
  • Stock Information
  • Founded
  • KALA 2009
  • FCUV 2012
  • Country
  • KALA United States
  • FCUV United States
  • Employees
  • KALA N/A
  • FCUV N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • KALA Health Care
  • FCUV Industrials
  • Exchange
  • KALA Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • KALA 26.2M
  • FCUV 27.6M
  • IPO Year
  • KALA 2017
  • FCUV N/A
  • Fundamental
  • Price
  • KALA $6.08
  • FCUV $3.67
  • Analyst Decision
  • KALA Strong Buy
  • FCUV
  • Analyst Count
  • KALA 3
  • FCUV 0
  • Target Price
  • KALA $14.00
  • FCUV N/A
  • AVG Volume (30 Days)
  • KALA 133.6K
  • FCUV 14.5K
  • Earning Date
  • KALA 08-05-2025
  • FCUV 08-13-2025
  • Dividend Yield
  • KALA N/A
  • FCUV N/A
  • EPS Growth
  • KALA N/A
  • FCUV N/A
  • EPS
  • KALA N/A
  • FCUV N/A
  • Revenue
  • KALA N/A
  • FCUV $408,887.00
  • Revenue This Year
  • KALA N/A
  • FCUV N/A
  • Revenue Next Year
  • KALA N/A
  • FCUV N/A
  • P/E Ratio
  • KALA N/A
  • FCUV N/A
  • Revenue Growth
  • KALA N/A
  • FCUV 6.49
  • 52 Week Low
  • KALA $2.92
  • FCUV $1.50
  • 52 Week High
  • KALA $11.20
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • KALA 58.29
  • FCUV 37.02
  • Support Level
  • KALA $5.39
  • FCUV $3.73
  • Resistance Level
  • KALA $7.00
  • FCUV $4.05
  • Average True Range (ATR)
  • KALA 0.71
  • FCUV 0.22
  • MACD
  • KALA 0.04
  • FCUV -0.03
  • Stochastic Oscillator
  • KALA 51.89
  • FCUV 13.82

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: